The demand for new weight-loss drugs is soaring, drawing attention to some significant drawbacks. These include the inconvenience of weekly injections, uncomfortable gastrointestinal side effects, and potential muscle and bone loss.
This situation is fueling competition among pharmaceutical companies. They aim to introduce improved versions of these medications. The goal is to surpass industry leaders like Eli Lilly and Novo Nordisk by enhancing the patient’s experience.
Leave a Reply